Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Observational Retrospective French Study in Patients With Previously Untreated, Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab Via an Early Access Program

NCT05308966 is registered in ClinicalTrials.gov with Groupe Francais De Pneumo-Cancerologie as lead sponsor.

NCT NCT05308966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05308966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Observational Retrospective French Study in Patients With Previously Untreated, Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab Via an Early Access Program
Lead sponsor
Groupe Francais De Pneumo-Cancerologie
Phase
Observational
Overall status
Completed
Start date
May 3, 2022
Completion date
August 27, 2025
Enrollment
204 (actual)
Sites
63

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural mesothelioma, unresectable malignant neoplasm